Joerg Kruetten
Executive Vice-President at Simon-Kucher & Partners and head of the Medtech competence center
Joerg Kruetten is a member of the executive committee of Simon-Kucher & Partners and heads the company´s global medical technology competence center. He is specialized in strategic corporate development, licensing & acquisitions, marketing, and pricing.
Within multinational assignments he has supported several leading medtech companies in improving their business performance. Joerg was previously a shareholder in a medical device start-up company specialized in R&D and OEM manufacturing. Prior to joining Simon-Kucher & Partners in 1997, he worked as a consultant with Anderson Consulting (now Accenture).
Joerg has published several articles on current management topics. He is an external lecturer at the University of Basel and the European School of Business in Tuttlingen as well as a speaker at international conferences. He studied mechanical engineering and business administration at the Technical Universities of Munich and Karlsruhe, specializing in corporate development.
2 blogs from the author
Posted on 15.05.2013
The importance of diagnostics in steering Europe’s healthcare future
With its Contract for a Healthy Future, the medical technology industry acknowledges its role and responsibility in maintaining high-quality, affordable healthcare in Europe despite an ageing population and constrained budgets. This industry commitment offers the much needed solutions to prove that innovation is not a cost driver but a facilitator for driving healthcare quality and efficiency in the future. From personalized medicine to disease monitoring, the role of the diagnostics industry will be crucial in managing healthcare spending.
Posted on 06.09.2011
Medtech industry must change its way of doing business to remain successful in the EU
Europe is an important and continuously growing market for medical technology products. Driven by budgetary pressure on the payer and provider levels as well as by strong competitive dynamics, the commercial climate for established medical technology companies is, however, deteriorating. The recent industry survey MedTech Barometer 2011 conducted by us (and with ‘us’, I mean global strategy and marketing consultancy Simon-Kucher & Partners) confirms the presence of increasing commercial challenges but still provides an overall positive short-term business outlook. Yet the longer-term outlook is less positive and suggests that in order to remain successful in the European market place, established players will have to adapt their way of doing business in the future.